A prospective, open label, Phase IV multicentre efficacy and safety investigation of Paliperidone Palmitate long-acting injection in elderly people with schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2019
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 04 Jun 2015 Status changed from not yet recruiting to discontinued as per Australian New Zealand Clinical Trials Registry.
- 27 Sep 2012 New trial record